ArticleInternational journal of molecular sciences2026
Short-Term Effects of Intradialytic Hypoxemia on Plasma Markers of Hypoxia.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Short episodes of intradialytic hypoxemia (IDH) are a common but still under-recognized complication of hemodialysis with clinically significant consequences. The aim of the study was to analyze the effect of IDH on the secretion of hypoxia-inducible factors 1 and 2 and sirtuin 1. The study group consisted of 49 chronic hemodialysis patients, mean age 58.8 ± 15.3 years. Pulse oximetry was continuously recorded throughout hemodialysis. Blood was collected three times during a single mid-week hemodialysis session and at the start of the next mid-week session to assess levels of sirtuin 1 (SIRT1), hypoxia-inducible factor 1 (HIF-1), and hypoxia-inducible factor 2 (HIF-2). IDH, defined as a decrease in blood oxygen saturation below 90%, occurred in 22 (45%) patients. The mean time of hypoxemia during dialysis was 0.52% of the total hemodialysis session time. Plasma SIRT1 and HIF-2 concentrations did not change significantly during hemodialysis, whereas plasma HIF-1 levels decreased significantly. Multiple regression analysis showed that pre-dialysis plasma SIRT1 and HIF-1 explained a significant portion of the variability of blood oxygen saturation during hemodialysis. Pre-dialysis plasma levels of sirtuin 1 and HIF-1 could be considered predictors of the decline in blood oxygen saturation during hemodialysis sessions; they also determine the degree of variability of this parameter during the procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.